Company research / ERNA
Ernexa Therapeutics Inc. (ERNA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2024-12-31, Ernexa Therapeutics Inc. reported revenue of $582.0K. Revenue grew 755.9% from the prior annual period.
Key ratios (year ended 2024-12-31)
83.5%
Gross margin
-2693.1%
Operating margin
-7652.7%
Net margin
-2618.4%
Return on year-end equity
755.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.